Therefore, we speculate that dsDNA released from tumor cells after CTX treatment in vivo also exists in form(s) that preferentially target APCs, which subsequently triggers the APC-intrinsic cGAS–STING pathway that leads to IFN-I production. This evidence concerns the gene STING1 and neoplasm.